focuses on investments exclusively within the

healthcare industry. We are actively seeking companies operating in the following segments:
 

	Specialty distribution focused on the alternate site (non-hospital) and pharmaceutical niches.
	Provider and payor outsourcing focused on contract management, staffing, utilization and disease management, billing, collections and other financial service providers.
	Pharmacy, infusion and home healthcare focused on chronic and acute disease pharmacy, hospice, institutional pharmacy and pharmacy benefit management.
	Outpatient and alternate site services focused on surgery centers, psychiatric services, dental and physician services, allied professional and diagnostic and laboratory services.
	Medical products manufacturing focused on capital equipment, medical and dental instruments, and other niche products.

We will structure the following types of transactions:


The majority of our investments are in medium-sized companies operating in the healthcare services segment. Target companies will be run by highly capable management teams and will exhibit identifiable competitive advantages and a significant barrier-to-entry, high return on invested capital, and high customer quality and retention rates. Investments of this type will be comprised primarily of prudently leveraged acquisitions of corporate subsidiaries, recapitalizations of founder-owned and operated entities and management-led acquisitions of independent companies. Total enterprise values will range typically from $40 million to $500 million.


A smaller portion of our investments are in growth-stage companies operating in the healthcare service, medical product and information technology segments. Target companies will be in high growth segments that exhibit high user adoption rates, compelling demographic trends, provide an unmet clinical or service need and reduce costs in the healthcare delivery system. Total enterprise values typically range from $5 million to $50 million.